Sun Pharma ILUMYA USFDA approval for psoriatic arthritis treatment

2 statements from 2 sources on Oct 30, 2026, 04:02–04:44 UTC

News

Updated Oct 30, 2026 04:44 UTC

Statements (2)

Bullish
Sun Pharmaceutical Industries received US FDA approval for ILUMYA to treat adults with active psoriatic arthritis
cnbctv18.comOct 30, 2026 04:44 UTCHigh importance
Bullish
Sun Pharma's ILUMYA receives USFDA approval for psoriatic arthritis treatment
business-standard.comOct 30, 2026 04:02 UTCHigh importance

Finance Pulse API

This page is built from the Finance Pulse API: every statement, source and sentiment above. One request returns it as JSON:

GET https://finance-pulse.p.rapidapi.com/v2/topics/be48a15b-a1c8-4ed9-8a3f-35a03aff9562